Rainier Acquisition Corporation (NASDAQ:RNAQU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “RNAQU” on Thursday, August 27, 2026.
The new SPAC intends to focus its search on the global life sciences industry.
Rainier Acquisition Corporation is to be led by Chief Executive Officer Gbola Amusa, Chief Financial Officer Guy Barudin and Chairman Isaac Manke, PhD. Jonas Grossman, Andrew Lam and Chidozie Ugwumba will serve on its Board of Directors.
Total SPAC deal count for 2026 year-to-date is now 146. This offering is expected to close on Friday, August 28, 2026.
Chardan is acting as the sole book-running manager for the offering. Goodwin Procter LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
